<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29898149</article-id><article-id pub-id-type="pmc">5985846</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>On-Pump Beating/Non-Beating CABG in Stable Angina Have Similar
Outcomes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dayan</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/><role>MD, PhD, FACC</role></contrib><contrib contrib-type="author"><name><surname>Paganini</surname><given-names>Juan Jose</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Marichal</surname><given-names>Alvaro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Brusich</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib></contrib-group><aff id="aff1"><label>1</label> Centro Cardiovascular Universitario, Hospital de
Clinicas, Universidad de la Republica Oriental del Uruguay. Montevideo,
Uruguay.</aff><aff id="aff2"><label>2</label> Instituto Nacional de Cirug&#x000ed;a Card&#x000ed;aca
(INCC), Montevideo, Uruguay.</aff><author-notes><corresp id="c1">Correspondence Address: Victor Dayan, 26 de Marzo, 3459/602 -
Montevideo, Uruguay. E-mail: <email>victor_dayan@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2018</year></pub-date><volume>33</volume><issue>2</issue><fpage>183</fpage><lpage>188</lpage><history><date date-type="received"><day>03</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>05</day><month>10</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>On pump beating/non-beating coronary artery bypass grafts (CABG) has been
compared in patients with unstable angina and/or severe left ventricular
dysfunction. There is scarce evidence regarding the beneficial use of
on-pump beating CABG in patients with stable angina and normal left
ventricular function. Our aim was to study the postoperative results using
both techniques in this group of patients.</p></sec><sec><title>Methods</title><p>One thousand one hundred and forty-five patients with stable angina underwent
on-pump isolated CABG in Uruguay from 2011 to 2015. Patients were grouped
into beating/non-beating CABG. Operative mortality and long-term survival
were evaluated as primary outcome. Logistic regression analysis was
performed to define the predictive role of aortic cross clamp (AXC) on
prolonged inotropic support, ventilator support and intraoperative
glycemia.</p></sec><sec><title>Results</title><p>Among the included patients, 988 underwent aortic cross clamp. No differences
were found in operative mortality, stroke and long-term survival among both
groups. Patients without AXC showed higher intraoperative values of glycemia
and higher incidence of postoperative prolonged mechanical ventilator
support (7.6% <italic>vs.</italic> 2.4%; <italic>P</italic>=0.001). The need
for prolonged inotropic support was lower in this group of patients (27.4%
<italic>vs.</italic> 49.5%; <italic>P</italic>&#x0003c;0.001).</p></sec><sec><title>Conclusion</title><p>On-pump beating CABG has similar operative mortality and long-term survival
compared with conventional AXC. Higher intraoperative glycemia and higher
incidence for prolonged mechanical ventilator is associated with on-pump
beating CABG. On the contrary, higher incidence for prolonged inotropic
support is associated with AXC. Taking these factors into consideration,
both techniques are safe and allow the surgeon to choose the most
comfortable option.</p></sec></abstract><kwd-group><kwd>Coronary Artery Bypass</kwd><kwd>Cardiopulmonary Bypass</kwd><kwd>Angina, Stable</kwd></kwd-group></article-meta></front><body><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute myocardial
infarction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AXC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Aortic cross clamp</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CK-MB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Creatine phosphokinase
MB isoenzyme</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EuroSCORE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European system for
cardiac operative risk evaluation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Internal thoracic
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left anterior descending
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PVD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Peripheral vascular
disease</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>The most common and widely used method for coronary artery bypass grafting (CABG)
involves the use of cardiopulmonary bypass (CPB) with aortic cross clamp (AXC) and
cardioplegic arrest. This technique allows the surgeon a still and bloodless
surgical field in which construction of distal coronary anastomosis is easy and
safer. Nonetheless, the use of CPB carries several disadvantages such as systemic
inflammatory reaction and risk for cerebral emboli. Therefore, several groups
support the use of CABG without CPB alleging better short and long-term outcomes
compared with patients with CPB. Data from the most recent randomized control study
has shown that although both techniques show differences in short-term outcomes
(more bleeding, renal failure and respiratory complications in patients with CPB;
decreased risk for early revascularization in CPB group) no differences were found
in long-term outcomes between both techniques<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>In spite using CPB, some groups have advocated not using AXC. Some of the arguments
for not using AXC are: non-uniform distribution of cardioplegia and therefore
myocardial damage<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>; higher risk for cardiac failure specially in
unstable high-risk patients<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup> and in patients with left ventricular
dysfunction<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Nonetheless, the only randomized control study in
this subject found higher risk of new irreversible myocardial injury in patients who
underwent CABG without AXC<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>Although much has been written comparing both techniques (CPB with and without AXC),
most of these studies refer to a high-risk cohort involving either unstable angina
or left ventricular failure.</p><p>The objective of this study was to evaluate immediate postoperative results and
long-term benefit on survival of patients with stable angina who underwent on-pump
beating CABG compared with arrested heart.</p></sec><sec sec-type="methods"><title>METHODS</title><p>Institutional review board from the Instituto Nacional de Cirug&#x000ed;a
Card&#x000ed;aca (Montevideo, Uruguay) approved the study. Patient data was provided
by the Fondo Nacional de Recursos (Resources National Fund). This Fund is the
governmental entity in charge of financing all cardiac surgery procedures in Uruguay
(private and public). As such, this agency has the responsibility of registering and
following all procedures performed in our country. Between January 2011 and December
2015, 1145 (988 with AXC) patients underwent on-pump isolated CABG surgery for
chronic ischemic heart disease. During this time-frame, the National registry
included data from 18 active surgeons. Informed consent for surgical procedure was
obtained in every case.</p><sec><title>Conventional CABG</title><p>CPB was established with aortic cannulation and bicaval venous drainage. Heparin
was administered at a dose of 300 IU/kg to achieve a target activated clotting
time greater than 450 s. Systemic temperature was kept between 32&#x000ba; and 34&#x000ba;C. The
aorta was cross-clamped, and myocardial protection was achieved with
intermittent antegrade and retrograde crystalloid cardioplegia (Buckberg or
Custodiol solution). The distal anastomoses were constructed with running
sutures of 7-0 polypropylene, and the proximal anastomoses were connected to the
ascending aorta with 6-0 polypropylene sutures using partial aortic
cross-clamp.</p><p>After the patient was weaned from CPB and decannulated, the heparin was reversed
with protamine infusion (1/1.5 rate).</p></sec><sec><title>On-pump Beating CABG</title><p>The CPB circuit was the same as that for conventional CABG. The operation was
continued with the assisted beating heart. The temperature of patients was kept
approximately 36&#x000ba;C without cooling (normothermic). The distal anastomoses were
constructed before the proximal anastomoses in most cases. The left anterior
descending artery (LAD) was revascularized first with the internal thoracic
artery (ITA). Regional myocardial immobilization and positioning was achieved
with a suction stabilizer (Octopus and Starfish, Medtronic). During anastomoses,
target vessel homeostasis was obtained with temporary occlusion of the proximal
coronary artery or intracoronary shunt, and/or a humidified carbon dioxide
blower was used for better visualization. Distal anastomoses were made with
running sutures of 7-0 polypropylene. The proximal anastomoses were created with
6-0 polypropylene sutures under a partial occlusion clamp in all cases. After
weaning from CPB and decannulation, the heparin was reversed with protamine
infusion (1/1.5 rate relative to heparin).</p></sec><sec><title>Definitions</title><p>Operative mortality was defined as death during 30 days after surgery or during
initial admission<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Prolonged inotropic support and prolonged
mechanical ventilation was defined as requirement of either for more than
12h<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Perioperative acute myocardial infarction (AMI)
was defined as the appearance of new Q-waves or a marked loss of R-wave forces
and peak creatine phosphokinase MB isoenzyme (CK-MB) fractions greater than five
times basal values<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>.</p><p>Categorical variables were expressed as absolute values (%), comparison between
them were performed using Chi square or Fisher exact test. Continuous variables
are expressed as mean&#x000b1;SD and comparisons were performed using Student T
test.</p><p>Baseline [age, gender, diabetes, hypertension, peripheral vascular disease,
smoker, creatininemia, previous CABG, previous angioplasty, chronic obstructive
pulmonary disease, renal failure, number of diseased coronary vessels, ejection
fraction, recent AMI, European system for cardiac operative risk evaluation
(EuroSCORE)] variables along with beating/non-beating heart were evaluated by
univariate analysis for each of the dependent variables studied (intraoperative
glycemia, prolonged inotropic support and prolonged ventilatory support). Those
which resulted significant with a <italic>P</italic>&#x0003c;0.1 were entered in the
multivariate regression. Survival was evaluated with Kaplan-Meier and log-rank
test used to compare survival between the groups. Logistic and linear
multivariate regression analysis were performed using the enter method.
Variables with a <italic>P</italic>&#x0003c;0.1 in the univariate analysis were
entered into the model. Cox regression was used to evaluate predictors for
long-term survival.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Basal demographic characteristics are shown in <xref ref-type="table" rid="t1">Table
1</xref>. Variables were similar among patients with and without AXC except for
higher incidence of peripheral vascular disease (PVD) (15.3% <italic>vs.</italic>
6.7%) and previous stroke (4.5% <italic>vs.</italic> 1.8%) in patients without AXC.
Almost all patients had three vessel disease and more than 30% of patients in each
group had left main disease.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic characteristics of the population (n=1145).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">AXC (988)</th><th align="center" rowspan="1" colspan="1">No AXC (157)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (SD)</td><td align="center" rowspan="1" colspan="1">65.1 (9.1)</td><td align="center" rowspan="1" colspan="1">63.9 (8.3)</td><td align="center" rowspan="1" colspan="1">0.162</td></tr><tr><td align="left" rowspan="1" colspan="1">Female (%)</td><td align="center" rowspan="1" colspan="1">274 (27.7)</td><td align="center" rowspan="1" colspan="1">42 (26.8)</td><td align="center" rowspan="1" colspan="1">0.798</td></tr><tr><td align="left" rowspan="1" colspan="1">HTN (%)</td><td align="center" rowspan="1" colspan="1">807 (81.7)</td><td align="center" rowspan="1" colspan="1">138 (87.9)</td><td align="center" rowspan="1" colspan="1">0.057</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoker (%)</td><td align="center" rowspan="1" colspan="1">347 (35.1)</td><td align="center" rowspan="1" colspan="1">61 (38.9)</td><td align="center" rowspan="1" colspan="1">0.364</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes NIR (%)</td><td align="center" rowspan="1" colspan="1">295 (29.9)</td><td align="center" rowspan="1" colspan="1">53 (33.8)</td><td align="center" rowspan="1" colspan="1">0.324</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes IR (%)</td><td align="center" rowspan="1" colspan="1">45 (4.6)</td><td align="center" rowspan="1" colspan="1">8 (5.1)</td><td align="center" rowspan="1" colspan="1">0.764</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine (mg/dl SD)</td><td align="center" rowspan="1" colspan="1">1.04 (0.51)</td><td align="center" rowspan="1" colspan="1">1.10 (1.03)</td><td align="center" rowspan="1" colspan="1">0.414</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous CABG (%)</td><td align="center" rowspan="1" colspan="1">5 (0.5)</td><td align="center" rowspan="1" colspan="1">1 (0.6)</td><td align="center" rowspan="1" colspan="1">0.833</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous PCI (%)</td><td align="center" rowspan="1" colspan="1">146 (14.8)</td><td align="center" rowspan="1" colspan="1">18 (11.5)</td><td align="center" rowspan="1" colspan="1">0.271</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD (%)</td><td align="center" rowspan="1" colspan="1">86 (8.7)</td><td align="center" rowspan="1" colspan="1">10 (6.4)</td><td align="center" rowspan="1" colspan="1">0.327</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal failure (%)</td><td align="center" rowspan="1" colspan="1">26 (2.6)</td><td align="center" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">0.306</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF (SD)</td><td align="center" rowspan="1" colspan="1">55.5 (10.3)</td><td align="center" rowspan="1" colspan="1">54.4 (11.01)</td><td align="center" rowspan="1" colspan="1">0.244</td></tr><tr><td align="left" rowspan="1" colspan="1">LMCA (%)</td><td align="center" rowspan="1" colspan="1">345 (34.9)</td><td align="center" rowspan="1" colspan="1">50 (31.8)</td><td align="center" rowspan="1" colspan="1">0.452</td></tr><tr><td align="left" rowspan="1" colspan="1">Vessel disease</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.270</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">21 (2.2)</td><td align="center" rowspan="1" colspan="1">4 (2.6)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">160 (16.4)</td><td align="center" rowspan="1" colspan="1">16 (10.4)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">791 (81.3)</td><td align="center" rowspan="1" colspan="1">134 (87.0)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Recent AMI (%)</td><td align="center" rowspan="1" colspan="1">55 (5.6)</td><td align="center" rowspan="1" colspan="1">6 (3.8)</td><td align="center" rowspan="1" colspan="1">0.366</td></tr><tr><td align="left" rowspan="1" colspan="1">PVD (%)</td><td align="center" rowspan="1" colspan="1">66 (6.7)</td><td align="center" rowspan="1" colspan="1">24 (15.3)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous Stroke (%)</td><td align="center" rowspan="1" colspan="1">18 (1.8)</td><td align="center" rowspan="1" colspan="1">7 (4.5)</td><td align="center" rowspan="1" colspan="1">0.036<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE (SD)</td><td align="center" rowspan="1" colspan="1">2.98 (3.84)</td><td align="center" rowspan="1" colspan="1">2.57 (2.25)</td><td align="center" rowspan="1" colspan="1">0.200</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p><italic>P</italic>&#x0003c;0.05.</p></fn><fn id="TFN2"><p>AMI=acute myocardial infarction; AXC = aortic cross clamp; CABG=coronary
artery bypass grafts; COPD=chronic obstructive pulmonary disease;
HTN=hypertension; IR=insulin requirement; LMCA=left main coronary
artery; LVEF=left ventricular ejection fraction; NIR=non-insulin
requirement; PCI=percutaneous coronary intervention; PVD=peripheral
vascular disease </p></fn></table-wrap-foot></table-wrap><p>Intra and postoperative outcomes are shown in <xref ref-type="table" rid="t2">Table
2</xref>. CPB time was slightly longer in patients with AXC (93.4&#x000b1;26.7
min <italic>vs.</italic> 81.6&#x000b1;22.2; <italic>P</italic>&#x0003c;0.001). Patients
without AXC showed higher intraoperative values of glycemia (1.99&#x000b1;0.69
<italic>vs</italic>. 1.77&#x000b1;0.51; <italic>P</italic>&#x0003c;0.001) and higher
incidence of postoperative prolonged ventilatory support (7.6% <italic>vs.</italic>
2.4%; <italic>P</italic>=0.001). Nonetheless, the need for prolonged inotropic
support was lower in this group of patients (27.4% <italic>vs.</italic> 49.5%;
<italic>P</italic>&#x0003c;0.001). No differences were found in operative mortality
or stroke between both groups.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Intra-and postoperative outcomes.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">AXC (988)</th><th align="center" rowspan="1" colspan="1">No AXC (157)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of bypass</td><td align="center" rowspan="1" colspan="1">3.1 (0.8)</td><td align="center" rowspan="1" colspan="1">2.9 (0.8)</td><td align="center" rowspan="1" colspan="1">0.140</td></tr><tr><td align="left" rowspan="1" colspan="1">LIMA (%)</td><td align="center" rowspan="1" colspan="1">954 (96.6)</td><td align="center" rowspan="1" colspan="1">147 (93.6)</td><td align="center" rowspan="1" colspan="1">0.076</td></tr><tr><td align="left" rowspan="1" colspan="1">BIMA (%)</td><td align="center" rowspan="1" colspan="1">122 (12.3)</td><td align="center" rowspan="1" colspan="1">17 (10.8)</td><td align="center" rowspan="1" colspan="1">0.588</td></tr><tr><td align="left" rowspan="1" colspan="1">CBP (min)</td><td align="center" rowspan="1" colspan="1">93.4 (26.7)</td><td align="center" rowspan="1" colspan="1">81.6 (22.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">XC (min)</td><td align="center" rowspan="1" colspan="1">54.1 (17.1)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Highest IO glycemia (mg/dl)</td><td align="center" rowspan="1" colspan="1">1.77 (0.51)</td><td align="center" rowspan="1" colspan="1">1.99 (0.69)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Prolonged inotropic support (%)</td><td align="center" rowspan="1" colspan="1">489 (49.5)</td><td align="center" rowspan="1" colspan="1">43 (27.4)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke (%)</td><td align="center" rowspan="1" colspan="1">11 (1.1)</td><td align="center" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">0.832</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurological dysfunction (%)</td><td align="center" rowspan="1" colspan="1">15 (1.5)</td><td align="center" rowspan="1" colspan="1">4 (2.5)</td><td align="center" rowspan="1" colspan="1">0.348</td></tr><tr><td align="left" rowspan="1" colspan="1">Prolonged ventilator support (%)</td><td align="center" rowspan="1" colspan="1">24 (2.4)</td><td align="center" rowspan="1" colspan="1">12 (7.6)</td><td align="center" rowspan="1" colspan="1">0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">ICU stay (days)</td><td align="center" rowspan="1" colspan="1">3.3 (3.9)</td><td align="center" rowspan="1" colspan="1">3.1 (2.9)</td><td align="center" rowspan="1" colspan="1">0.471</td></tr><tr><td align="left" rowspan="1" colspan="1">Perioperative AMI (%)</td><td align="center" rowspan="1" colspan="1">17 (1.7)</td><td align="center" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">0.098</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemodialysis (%)</td><td align="center" rowspan="1" colspan="1">9 (0.9)</td><td align="center" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">0.665</td></tr><tr><td align="left" rowspan="1" colspan="1">Operative mortality (%)</td><td align="center" rowspan="1" colspan="1">37 (3.7)</td><td align="center" rowspan="1" colspan="1">4 (2.5)</td><td align="center" rowspan="1" colspan="1">0.453</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>AMI=acute myocardial infarction; AXC=aortic cross clamp; BIMA=bilateral
internal mammary artery; CPB=cardiopulmonary bypass; IO=intra-operative;
ICU=intensive care unit; LIMA=left internal mammary artery; XC=cross
clamp</p></fn></table-wrap-foot></table-wrap><p>Long-term survival for AXC and non AXC was similar (5-year survival 86.8&#x000b1;0.2
<italic>vs.</italic> 87.7&#x000b1;0.3%; <italic>P</italic>=0.340) (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Overall survival for patients with stable angina who underwent isolated
on-pump CABG. Green line - Aortic cross clamp. Blue line - beating
heart.</p><p>AXC=Aortic cross clamp</p></caption><graphic xlink:href="rbccv-33-02-0183-g01"/></fig>
</p><p>In order to adjust for baseline differences between groups, logistic regression
analysis was performed to define the predictive role of AXC on prolonged inotropic
support, ventilator support, intraoperative glycemia, operative mortality and
survival.</p><p>Independent predictors for intraoperative glycemia were: diabetes (non-insulin
requirement and insulin requirement), CPB time, and AXC (protective) (<xref ref-type="table" rid="t3">Table 3</xref>). Along with CPB time and EuroSCORE,
AXC was found to be an independent predictor for prolonged postoperative inotropic
support (<xref ref-type="table" rid="t4">Table 4</xref>). Regarding predictors for
prolonged ventilatory support: AXC was protective and higher EuroSCORE was
associated with increased risk (<xref ref-type="table" rid="t5">Table 5</xref>).
Operative mortality and survival were not influenced by AXC.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Predictors for intraoperative glycemia.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">B coefficient (95%CI)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">NIR Diabetes</td><td align="center" rowspan="1" colspan="1">0.23 (0.16;0.30)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">IR Diabetes</td><td align="center" rowspan="1" colspan="1">0.35 (0.22;0.48)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time</td><td align="center" rowspan="1" colspan="1">0.003 (0.002;0.004)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">AXC</td><td align="center" rowspan="1" colspan="1">-0.24 (-0.32;-0.16)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>AXC=aortic cross clamp; CPB=cardiopulmonary bypass; IR=insulin
requirement; NIR=non-insulin requirement</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Independent predictors for prolonged inotropic support.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">HR (95%CI)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AXC</td><td align="center" rowspan="1" colspan="1">2.19 (1.47;3.25)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">CBP time</td><td align="center" rowspan="1" colspan="1">1.009 (1.003;1.014)</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE</td><td align="center" rowspan="1" colspan="1">1.07 (1.01;1.13)</td><td align="center" rowspan="1" colspan="1">0.020</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>AXC=aortic cross clamp; CBP=cardiopulmonary bypass</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Independent predictors for prolonged ventilation support.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">HR (95%CI)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">EuroSCORE</td><td align="center" rowspan="1" colspan="1">1.08(1.01;1.16)</td><td align="center" rowspan="1" colspan="1">0.029</td></tr><tr><td align="left" rowspan="1" colspan="1">AXC</td><td align="center" rowspan="1" colspan="1">0.23 (0.10;0.50)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>AXC=aortic cross clamp</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Almost all data in the literature comparing on-pump beating and non-beating CABG is
focused on a high-risk population either due to the presence of unstable angina or
left ventricular dysfunction. There is very limited data regarding what to do in
patients with stable angina. Our results show that although some differences were
noted between both techniques in the immediate postoperative period, operative
mortality and long-term survival is similar.</p><p>Various studies have shown that off-pump CABG is a good alternative technique for
high risk patients with comparable results to on-pump CABG<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Some argue that
off-pump CABG is a highly demanding surgical technique leading more frequently to
incomplete revascularization resulting in higher incidence of short term
revascularization procedures<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Nonetheless, the presence of diffuse
atherosclerotic disease of the ascending aorta imply high risk for stroke and
embolic complications with the use of AXC rendering off pump an attractive
alternative.</p><p>There is evidence that with conventional CABG the arrested heart may not be as well
protected from ischemia as the beating-heart technique<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. This major drawback
of AXC CPB surgery is most important in unstable patients and patients with left
ventricular dysfunction. Several retrospective studies have shown the beneficial use
of on-pump beating heart CABG in these patients<sup>[<xref rid="r4" ref-type="bibr">4</xref>-<xref rid="r6" ref-type="bibr">6</xref>]</sup>. In patients with end
stage coronary artery disease, it has been proposed that myocardial protection with
AXC is detrimental and leads to hemodynamic failure in these
patients<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Furthermore, in patients with severe left
ventricular dysfunction, myocardial protection with AXC has been shown to be
associated with worse short-term outcomes<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>However, the only randomized control study performed in this group of patients has
shown quite the opposite<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Patients with severe left ventricular dysfunction
randomized to on-pump beating CABG showed higher incidence of new irreversible
myocardial and on six months follow-up, only patients with AXC demonstrated an
improvement in ventricular geometry. The most likely mechanism proposed was
inadequate coronary perfusion to distal myocardial territories in patients with
severe proximal coronary disease<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>In patients with stable angina and normal ejection fraction, our results show that
both techniques are comparable regarding operative mortality and long-term survival.
We have shown that patients with on-pump beating CABG have higher intraoperative
values of glycemia. It is well-known the association between acute coronary
syndromes and hyperglycemia<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. Higher glycemia in this group of patients
could therefore be explained by the ischemic burden associated with on-pump beating
CABG. AXC was associated with prolonged inotropic support. Concomitantly, patients
who underwent AXC had longer CPB time. Although the predictive role of AXC for
prolonged inotropic support derives from multivariate logistic regression, it is
difficult to separate the influence of longer CPB times exerted by this group of
patients. Similar to our findings, other authors have also shown CPB to be an
important predictor for prolonged inotropic support<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Although AXC showed
to be a predictor for prolonged inotropic support, it has an opposite effect on
prolonged mechanical ventilation. This could be explained by the increased ischemic
burden exerted by on-pump beating CABG which therefore derive in diastolic
dysfunction and pulmonary edema. Previous data has shown similar ultrastructural
abnormalities in patients who underwent beating and arrested heart
procedures<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. Nonetheless, even though logistic regression aims
at correcting baseline differences, patients with AXC were less sicker and this
could contribute to our findings. Although our findings are supported by the only
randomized control trial published up to date, in order to confirm these mechanistic
explanations, further research into circulating myocardial damage markers and lung
function (arterial blood gases) parameters are required.</p><p>Despite these postoperative differences, on-pump beating CABG is reliable and
acceptable in patients with stable coronary artery disease and normal left
ventricular function.</p><sec><title>Limitations</title><p>The present study is a retrospective analysis of our nation registry. Therefore,
it is subject to selection bias and subject to heterogeneity among health
institutions. The latter refers to the fact that some institutions promote one
technique over the other and therefore their results are biased. Furthermore,
since our data is extracted from the National database, indications or reasons
for choosing one technique over the other one is not present. Similarly,
information regarding ascending aorta calcification although very valuable is
not present in the National database. Unfortunately, no data regarding
myocardial damage markers and arterial blood gases were registered. Therefore,
solid mechanistic explanations for the differences in prolonged mechanical
ventilatory and inotropic support cannot be stated. Patency of grafts could not
be evaluated since routine angiography is not performed after CABG.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>On-pump beating CABG has similar operative mortality and long-term survival compared
with conventional AXC. Higher intraoperative glycemia and higher incidence for
prolonged mechanical ventilation is associated with on-pump beating CABG. On the
contrary, higher incidence for prolonged inotropic support is associated with AXC.
Taking these factors into consideration, both techniques are safe and allow the
surgeon to choose for the most comfortable option.</p><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">VD</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JJP</td><td align="left" valign="top" rowspan="1" colspan="1">Agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AM</td><td align="left" valign="top" rowspan="1" colspan="1">Agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DB</td><td align="left" valign="top" rowspan="1" colspan="1">Agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Instituto Nacional de Cirug&#x000ed;a
Card&#x000ed;aca, Montevideo, Uruguay.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamy</surname><given-names>A</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Taggart</surname><given-names>DP</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Paolasso</surname><given-names>E</given-names></name><etal/><collab>CORONARY Investigators</collab></person-group><article-title>Off-pump or on-pump coronary-artery bypass grafting at 30
days</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><issue>16</issue><fpage>1489</fpage><lpage>1497</lpage><pub-id pub-id-type="pmid">22449296</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamy</surname><given-names>A</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Taggart</surname><given-names>DP</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Straka</surname><given-names>Z</given-names></name><etal/><collab>CORONARY Investigators</collab></person-group><article-title>Five-year outcomes after off-pump or on-pump coronary-artery
bypass grafting</article-title><source>N Engl J Med</source><year>2016</year><volume>375</volume><issue>24</issue><fpage>2359</fpage><lpage>2368</lpage><pub-id pub-id-type="pmid">27771985</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>IG</given-names></name><name><surname>Shearer</surname><given-names>ST</given-names></name><name><surname>MacDonald</surname><given-names>MJ</given-names></name><name><surname>Gott</surname><given-names>JP</given-names></name><name><surname>Brown</surname><given-names>WM 3rd</given-names></name><name><surname>Vinten-Johansen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Myocardial distribution of antegrade cold crystalloid and tepid
blood cardioplegia</article-title><source>Ann Thorac Surg</source><year>1998</year><volume>65</volume><issue>6</issue><fpage>1610</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">9647067</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>E</given-names></name><name><surname>Stalder</surname><given-names>N</given-names></name><name><surname>von Segesser</surname><given-names>LK</given-names></name></person-group><article-title>On-pump beating heart coronary surgery for high risk patients
requiring emergency multiple coronary artery bypass grafting</article-title><source>J Cardiothorac Surg</source><year>2008</year><volume>3</volume><fpage>38</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">18597673</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyahara</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>A</given-names></name><name><surname>Takemura</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Sawaki</surname><given-names>S</given-names></name><name><surname>Yoshioka</surname><given-names>T</given-names></name><etal/></person-group><article-title>On-pump beating-heart coronary artery bypass grafting after acute
myocardial infarction has lower mortality and morbidity</article-title><source>J Thorac Cardiovasc Surg</source><year>2008</year><volume>135</volume><issue>3</issue><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">18329463</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulcan</surname><given-names>O</given-names></name><name><surname>Turkoz</surname><given-names>R</given-names></name><name><surname>Turkoz</surname><given-names>A</given-names></name><name><surname>Caliskan</surname><given-names>E</given-names></name><name><surname>Sezgin</surname><given-names>AT</given-names></name></person-group><article-title>On-pump/beating-heart myocardial protection for isolated or
combined coronary artery bypass grafting in patients with severe left
ventricle dysfunction: assessment of myocardial function and clinical
outcome</article-title><source>Heart Surg Forum</source><year>2004</year><volume>8</volume><issue>3</issue><fpage>E178</fpage><lpage>E182</lpage></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pegg</surname><given-names>TJ</given-names></name><name><surname>Selvanayagam</surname><given-names>JB</given-names></name><name><surname>Francis</surname><given-names>JM</given-names></name><name><surname>Karamitsos</surname><given-names>TD</given-names></name><name><surname>Maunsell</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>LM</given-names></name><etal/></person-group><article-title>A randomized trial of on-pump beating heart and conventional
cardioplegic arrest in coronary artery bypass surgery patients with impaired
left ventricular function using cardiac magnetic resonance imaging and
biochemical markers</article-title><source>Circulation</source><year>2008</year><volume>118</volume><issue>21</issue><fpage>2130</fpage><lpage>2138</lpage><pub-id pub-id-type="pmid">18981306</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>JP</given-names></name><name><surname>Mavroudis</surname><given-names>C</given-names></name><name><surname>Jacobs</surname><given-names>ML</given-names></name><name><surname>Maruszewski</surname><given-names>B</given-names></name><name><surname>Tchervenkov</surname><given-names>CI</given-names></name><name><surname>Lacour-Gayet</surname><given-names>FG</given-names></name><etal/><collab>STS Congenital Database Taskforce</collab><collab>Joint EACTS-STS Congenital Database Committee</collab></person-group><article-title>What is operative mortality? Defining death in a surgical
registry database: a report of the STS Congenital Database Taskforce and the
Joint EACTS-STS Congenital Database Committee</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>81</volume><issue>5</issue><fpage>1937</fpage><lpage>1941</lpage><pub-id pub-id-type="pmid">16631716</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Hernandez</surname><given-names>AF</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Dokholyan</surname><given-names>RS</given-names></name><name><surname>O'Brien</surname><given-names>SM</given-names></name><name><surname>Smith</surname><given-names>PK</given-names></name><etal/></person-group><article-title>Postoperative inotrope and vasopressor use following CABG:
outcome data from the CAPS-care study</article-title><source>J Card Surg</source><year>2011</year><volume>26</volume><issue>6</issue><fpage>572</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">21951076</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thielmann</surname><given-names>M</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Al-Attar</surname><given-names>N</given-names></name><name><surname>Bulluck</surname><given-names>H</given-names></name><name><surname>Bisleri</surname><given-names>G</given-names></name><name><surname>Bunge</surname><given-names>JJH</given-names></name><etal/></person-group><article-title>ESC Joint Working Groups on Cardiovascular Surgery and the
Cellular Biology of the Heart Position Paper: Perioperative myocardial
injury and infarction in patients undergoing coronary artery bypass graft
surgery</article-title><source>Eur Heart J.</source><year>2017</year><volume>38</volume><issue>31</issue><fpage>2392</fpage><lpage>2407</lpage><pub-id pub-id-type="pmid">28821170</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gundry</surname><given-names>SR</given-names></name><name><surname>Romano</surname><given-names>MA</given-names></name><name><surname>Shattuck</surname><given-names>OH</given-names></name><name><surname>Razzouk</surname><given-names>AJ</given-names></name><name><surname>Bailey</surname><given-names>LL</given-names></name></person-group><article-title>Seven-year follow-up of coronary artery bypasses performed with
and without cardiopulmonary bypass</article-title><source>J Thorac Cardiovasc Surg</source><year>1998</year><volume>115</volume><issue>6</issue><fpage>1273</fpage><lpage>1277</lpage><pub-id pub-id-type="pmid">9628668</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>NE</given-names></name><name><surname>Souza</surname><given-names>A</given-names></name><name><surname>Mister</surname><given-names>R</given-names></name><name><surname>Flather</surname><given-names>M</given-names></name><name><surname>Clague</surname><given-names>J</given-names></name><name><surname>Davies</surname><given-names>S</given-names></name><etal/></person-group><article-title>A randomized comparison of off-pump and on-pump multivessel
coronary-artery bypass surgery</article-title><source>N Engl J Med</source><year>2004</year><volume>350</volume><issue>1</issue><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">14702424</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krejca</surname><given-names>M</given-names></name><name><surname>Skiba</surname><given-names>J</given-names></name><name><surname>Szmagala</surname><given-names>P</given-names></name><name><surname>Gburek</surname><given-names>T</given-names></name><name><surname>Bochenek</surname><given-names>A</given-names></name></person-group><article-title>Cardiac troponin T release during coronary surgery using
intermittent cross-clamp with fibrillation, on-pump and off-pump beating
heart</article-title><source>Eur J Cardiothorac Surg</source><year>1999</year><volume>16</volume><issue>3</issue><fpage>337</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">10554854</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prifti</surname><given-names>E</given-names></name><name><surname>Bonacchi</surname><given-names>M</given-names></name><name><surname>Giunti</surname><given-names>G</given-names></name><name><surname>Frati</surname><given-names>G</given-names></name><name><surname>Proietti</surname><given-names>P</given-names></name><name><surname>Leacche</surname><given-names>M</given-names></name><etal/></person-group><article-title>Does on-pump/beating-heart coronary artery bypass grafting offer
better outcome in end-stage coronary artery disease
patients?</article-title><source>J Card Surg</source><year>2000</year><volume>15</volume><issue>6</issue><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">11678463</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosiborod</surname><given-names>M</given-names></name><name><surname>Rathore</surname><given-names>SS</given-names></name><name><surname>Inzucchi</surname><given-names>SE</given-names></name><name><surname>Masoudi</surname><given-names>FA</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Havranek</surname><given-names>EP</given-names></name><etal/></person-group><article-title>Admission glucose and mortality in elderly patients hospitalized
with acute myocardial infarction: implications for patients with and without
recognized diabetes</article-title><source>Circulation</source><year>2005</year><volume>111</volume><issue>23</issue><fpage>3078</fpage><lpage>3086</lpage><pub-id pub-id-type="pmid">15939812</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinlay</surname><given-names>KH</given-names></name><name><surname>Schinderle</surname><given-names>DB</given-names></name><name><surname>Swaminathan</surname><given-names>M</given-names></name><name><surname>Podgoreanu</surname><given-names>MV</given-names></name><name><surname>Milano</surname><given-names>CA</given-names></name><name><surname>Messier</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Predictors of inotrope use during separation from cardiopulmonary
bypass</article-title><source>J Cardiothorac Vasc Anesth</source><year>2004</year><volume>18</volume><issue>4</issue><fpage>404</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">15365918</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cueva</surname><given-names>CN</given-names></name><name><surname>Rocha</surname><given-names>MS</given-names></name><name><surname>Mendes</surname><given-names>CM</given-names></name><name><surname>Freitas</surname><given-names>LA</given-names></name><name><surname>Baucia</surname><given-names>JA</given-names></name><name><surname>Badar&#x000f3;</surname><given-names>R</given-names></name></person-group><article-title>Clinical and ultramicroscopic myocardial randomized study of
beating versus arrested heart for mitral surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2013</year><volume>28</volume><issue>2</issue><fpage>270</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">23939325</pub-id></element-citation></ref></ref-list></back></article>